106 related articles for article (PubMed ID: 10840995)
1. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
Hegele RA; Cao H; Hanley AJ; Zinman B; Harris SB; Anderson CM
Diabetes Care; 2000 Jun; 23(6):775-8. PubMed ID: 10840995
[TBL] [Abstract][Full Text] [Related]
2. The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B; Connelly PW
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):217-22. PubMed ID: 10634821
[TBL] [Abstract][Full Text] [Related]
3. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
J Clin Endocrinol Metab; 1999 Mar; 84(3):1077-82. PubMed ID: 10084598
[TBL] [Abstract][Full Text] [Related]
4. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
[TBL] [Abstract][Full Text] [Related]
5. Genes, environment and Oji-Cree type 2 diabetes.
Hegele RA; Zinman B; Hanley AJ; Harris SB; Barrett PH; Cao H
Clin Biochem; 2003 May; 36(3):163-70. PubMed ID: 12726923
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
[TBL] [Abstract][Full Text] [Related]
7. Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
Int J Obes Relat Metab Disord; 2000 Aug; 24(8):1062-4. PubMed ID: 10951547
[TBL] [Abstract][Full Text] [Related]
8. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.
Ley SH; Hegele RA; Connelly PW; Harris SB; Mamakeesick M; Cao H; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
Cardiovasc Diabetol; 2010 Aug; 9():39. PubMed ID: 20716378
[TBL] [Abstract][Full Text] [Related]
9. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
Triggs-Raine BL; Kirkpatrick RD; Kelly SL; Norquay LD; Cattini PA; Yamagata K; Hanley AJ; Zinman B; Harris SB; Barrett PH; Hegele RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4614-9. PubMed ID: 11904371
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
Pollex RL; Hanley AJ; Zinman B; Harris SB; Hegele RA
Int J Obes (Lond); 2006 Mar; 30(3):484-91. PubMed ID: 16276364
[TBL] [Abstract][Full Text] [Related]
11. Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians.
Hegele RA
Curr Atheroscler Rep; 2001 May; 3(3):216-21. PubMed ID: 11286643
[TBL] [Abstract][Full Text] [Related]
12. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.
Harries LW; Sloman MJ; Sellers EA; Hattersley AT; Ellard S
Diabetes; 2008 Jul; 57(7):1978-82. PubMed ID: 18586913
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
Diabetes Care; 1999 Mar; 22(3):524. PubMed ID: 10097940
[No Abstract] [Full Text] [Related]
14. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Hanley AJ; Zinman B; Harris SB; Anderson CM
J Hum Genet; 2000; 45(3):184-7. PubMed ID: 10807546
[TBL] [Abstract][Full Text] [Related]
15. [HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes].
Yamagata K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():171-5. PubMed ID: 15779364
[No Abstract] [Full Text] [Related]
16. HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study.
Ley SH; Hegele RA; Harris SB; Mamakeesick M; Cao H; Connelly PW; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
BMC Med Genet; 2011 Jan; 12():1. PubMed ID: 21208426
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes.
Sellers EA; Triggs-Raine B; Rockman-Greenberg C; Dean HJ
Diabetes Care; 2002 Dec; 25(12):2202-6. PubMed ID: 12453961
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Baier LJ; Permana PA; Traurig M; Dobberfuhl A; Wiedrich C; Sutherland J; Thuillez P; Luczy-Bachman G; Hara M; Horikawa Y; Hinokio Y; Hanson RL; Bogardus C
Diabetes Care; 2000 Mar; 23(3):302-4. PubMed ID: 10868855
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree.
Mok A; Cao H; Zinman B; Hanley AJ; Harris SB; Kennedy BP; Hegele RA
J Clin Endocrinol Metab; 2002 Feb; 87(2):724-7. PubMed ID: 11836311
[TBL] [Abstract][Full Text] [Related]
20. Human hepatocyte nuclear factor-1 beta (HNF1B) 1968A/G polymorphism.
Cao H; Hegele RA
J Hum Genet; 2000; 45(2):98-9. PubMed ID: 10721673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]